Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast
- PMID: 7074570
- DOI: 10.1002/1097-0142(19820615)49:12<2534::aid-cncr2820491221>3.0.co;2-j
Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast
Abstract
Tissue specimens from 27 patients with mammary fibrocystic disease were assayed for estrogen (ER) and progestin (PR) receptors. Seventeen patients (63%) had ER-positive lesions (greater than 5 fmol/mg protein). A progression in ER presence was noted from fibrocystic disease (35%) and fibrosing adenosis (50%) to lobular and ductal hyperplasia (85%). Similarly, ER content increased from 14.5 +/- 13 fmol/mg cytosol protein in fibrocystic disease and fibrosing adenosis to 31.5 +/- 23 fmol/mg protein in epithelial hyperplastic lesions. Furthermore, the ER-PR couple was only encountered in lobular and ductal hyperplasia. The authors' data indicate that the incidence of steroid receptor parallels the intensity of hyperplasia in benign breast disease.
Similar articles
-
Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases.Zentralbl Pathol. 1991;137(3):227-32. Zentralbl Pathol. 1991. PMID: 1931896
-
Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features.Int J Cancer. 1986 Jan 15;37(1):7-10. doi: 10.1002/ijc.2910370103. Int J Cancer. 1986. PMID: 3000957
-
Estrogen and progesterone receptors in human breast cancer. Correlation with histologic subtype and degree of differentiation.Cancer. 1986 Sep 1;58(5):1076-81. doi: 10.1002/1097-0142(19860901)58:5<1076::aid-cncr2820580516>3.0.co;2-m. Cancer. 1986. PMID: 3015374
-
[Steroid hormone receptor status and other immunohistochemical prognostic markers in benign and malignant diseases of the breast].Zentralbl Chir. 1998;123 Suppl 5:14-8. Zentralbl Chir. 1998. PMID: 10063564 Review. German.
-
William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis.Breast Cancer Res Treat. 1993;27(1-2):3-15. doi: 10.1007/BF00683189. Breast Cancer Res Treat. 1993. PMID: 8260728 Review.
Cited by
-
Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease.Br Med J (Clin Res Ed). 1987 Aug 22;295(6596):464-6. doi: 10.1136/bmj.295.6596.464. Br Med J (Clin Res Ed). 1987. PMID: 3117172 Free PMC article. Clinical Trial.
-
Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profile in non-malignant and malignant states.Br J Cancer. 1988 Nov;58(5):594-9. doi: 10.1038/bjc.1988.266. Br J Cancer. 1988. PMID: 3219269 Free PMC article.
-
Chemoprevention of breast cancer: implications for postmenopausal women.Drugs Aging. 2002;19(1):43-78. doi: 10.2165/00002512-200219010-00004. Drugs Aging. 2002. PMID: 11929326 Review.
-
A Ternary Mixture of Common Chemicals Perturbs Benign Human Breast Epithelial Cells More Than the Same Chemicals Do Individually.Toxicol Sci. 2018 Sep 1;165(1):131-144. doi: 10.1093/toxsci/kfy126. Toxicol Sci. 2018. PMID: 29846718 Free PMC article.
-
Immunolocalization of estrogen-producing and metabolizing enzymes in benign breast disease: comparison with normal breast and breast carcinoma.Cancer Sci. 2010 Oct;101(10):2286-92. doi: 10.1111/j.1349-7006.2010.01673.x. Epub 2010 Aug 2. Cancer Sci. 2010. PMID: 20682005 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials